Xintong Wang, Wenjie Hu, Xiaohui Cheng, Jie Zhu, Weiming Zhu, Junfeng Zhang, Yi Li, Zhen Huang, Jiangning Chen
{"title":"Epithelial CREB1-miR-215-5p/3p-ZEB2/STC1 axis regulates epithelial-mesenchymal transition-associated intestinal fibrotic remodeling in Crohn's disease.","authors":"Xintong Wang, Wenjie Hu, Xiaohui Cheng, Jie Zhu, Weiming Zhu, Junfeng Zhang, Yi Li, Zhen Huang, Jiangning Chen","doi":"10.1016/j.jcmgh.2026.101930","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101930","url":null,"abstract":"<p><strong>Background & aims: </strong>Intestinal fibrosis is a common and intractable complication of Crohn's disease (CD) that leads to strictures and often requires surgery. Although epithelial-mesenchymal transition (EMT) drives this process, the roles of epithelial-derived microRNAs during EMT remain poorly defined. We aimed to define the function of miR-215-5p/3p in EMT and evaluate their therapeutic potential in established intestinal fibrosis.</p><p><strong>Methods: </strong>Using human fibrostenotic CD tissues and a TNBS-induced murine colitis model, we identified epithelial-enriched miRNAs by small RNA sequencing, qRT-PCR, in situ hybridization, and magnetic cell sorting. Mechanistic studies used bioinformatics, luciferase assays, DNA pull-down, mass spectrometry, CUT&RUN, EMSA, patient-derived intestinal organoids, and loss- and gain-of-function experiments. The antifibrotic effects of combined agomiR-215-5p/3p were evaluated by histology, collagen quantification, and EMT marker analysis.</p><p><strong>Results: </strong>miR-215-5p/3p were among the most downregulated epithelial-enriched miRNAs in fibrotic tissues, and their reduction correlated with disease progression and EMT activation in human CD strictures and murine fibrosis. Restoring miR-215-5p/3p in patient-derived intestinal organoids suppressed EMT and fibroblast activation under fibrogenic conditions. Mechanistically, miR-215-5p and miR-215-3p directly targeted the 3'UTRs of ZEB2 and STC1, respectively, and their expression was transcriptionally activated by CREB1, which was downregulated in CD strictures. In vivo, combined agomiR-215-5p/3p reduced colonic hydroxyproline content by ∼55.6% and collagen deposition by ∼47.7%, reversed EMT markers, and attenuated established fibrosis. ZEB2 or STC1 re-expression with mutant 3'UTRs abolished these effects, while miR-215-5p/3p inhibition exacerbated TNBS-induced fibrosis.</p><p><strong>Conclusions: </strong>We identified a CREB1-miR-215-5p/3p-ZEB2/STC1 axis in intestinal fibrosis, elucidating a mechanism of epithelial-mesenchymal reprogramming and supporting miRNA replacement therapy for CD strictures.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101930"},"PeriodicalIF":8.2,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lisha Wu, Zhengxiong Tao, Gan Wang, Yaling Chen, Zheng Sun, Shuang Lu
{"title":"Prebiotic mannuronate oligosaccharides fortify the mucus barrier by binding host NLRP6 in a microbiota-independent manner.","authors":"Lisha Wu, Zhengxiong Tao, Gan Wang, Yaling Chen, Zheng Sun, Shuang Lu","doi":"10.1016/j.jcmgh.2026.101929","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101929","url":null,"abstract":"<p><p>The beneficial effects of prebiotics are conventionally attributed to their fermentation by the gut microbiota. Here, we uncover a direct, microbiota-independent mechanism by which mannuronate oligosaccharides (MAOS) fortify the mucus barrier in a structure-dependent manner. We demonstrate that MAOS functions as a direct host agonist by binding the NLRP6 pyrin domain at Arg87 with high affinity (K<sub>D</sub> = 0.9 μM). This binding event triggers NLRP6 inflammasome assembly and subsequent caspase-1 activation, leading to the formation of non-lytic GSDMD pores specifically at the apical membrane of goblet cells. These pores facilitate mucin 2 (Muc2) secretion, thereby enhancing mucosal defense and limiting bacterial adhesion. Our findings establish MAOS as a novel class of NLRP6 agonist that enhances mucosal barrier function through a GSDMD-dependent secretory mechanism. This work highlights that specific glycan structures, rather than microbial fermentation, can directly engage host immune receptors. This opens a new avenue for developing structure-guided glycan-based therapeutics that act directly on the host immune system to treat inflammatory bowel disease (IBD) and other mucus barrier disorders.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101929"},"PeriodicalIF":8.2,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhaode Feng, Fangjun Chen, Jiajia Xiao, Anhui Du, Jianmin Deng, Sirui Wu, Yi Zhang, Xiaokang Li, Adi Zheng, Hao Li
{"title":"Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver disease.","authors":"Zhaode Feng, Fangjun Chen, Jiajia Xiao, Anhui Du, Jianmin Deng, Sirui Wu, Yi Zhang, Xiaokang Li, Adi Zheng, Hao Li","doi":"10.1016/j.jcmgh.2026.101928","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101928","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition that progresses from simple steatosis to advanced fibrosis, significantly affecting liver function and systemic health. Despite its widespread impact, therapeutic options remain limited, highlighting the urgent need for comprehensive exploration to identify potential therapeutic targets.</p><p><strong>Methods: </strong>We developed an analysis pipeline anchored on liver gene expression, integrating differential meta-analysis of transcriptomic data across three MASLD stages, transcriptome-wide Mendelian randomization (MR), and transcriptome-wide association studies (TWAS) to identify candidate genes potentially involved in MASLD progression. We further prioritized these genes using a scoring system that incorporated gene expression-clinical phenotype correlation meta-analysis, proteome-wide association studies (PWAS), and external genetic data from the GWAS Catalog and ExPheWAS. In addition, single-nucleus RNA sequencing (snRNA-seq) analysis was performed to characterize the expression patterns of prioritized genes across liver cell types and disease stages.</p><p><strong>Results: </strong>By integrating transcriptomic, genetic, and phenotypic evidence, we prioritized 39 candidate regulators of MASLD. snRNA-seq analysis of liver cells from healthy to cirrhotic stages revealed stage- and cell-type-specific expression patterns of these genes. Through experimental validation in a lipid overload hepatocyte model, we confirmed a role for MLIP in lipid metabolism. To facilitate community access and data exploration, these data were organized and deposited into a publicly accessible interactive web portal (www.masldportal.net).</p><p><strong>Conclusions: </strong>Our integrative, liver expression-anchored multi-omics framework prioritized 39 candidate regulators of MASLD and highlighted MLIP as a functional modulator of hepatocellular lipid accumulation. These results provide a systematic foundation for understanding MASLD biology and for guiding future mechanistic and therapeutic studies.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101928"},"PeriodicalIF":8.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaojing Yang, André A Weber, Gabriela Bulli, Mingyu Zhang, Samuel Wang, Max Chang, Christopher Benner, Lars Bode, Shujuan Chen, Robert H Tukey
{"title":"Maternal Milk 3'-Sialyllactose Promotes Neonatal Intestinal Maturation and Prevents Hyperbilirubinemia through an HNF4α-Associated Pathway.","authors":"Xiaojing Yang, André A Weber, Gabriela Bulli, Mingyu Zhang, Samuel Wang, Max Chang, Christopher Benner, Lars Bode, Shujuan Chen, Robert H Tukey","doi":"10.1016/j.jcmgh.2026.101924","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101924","url":null,"abstract":"<p><strong>Background and aims: </strong>Proper development of the neonatal small intestine is critical for nutrient absorption, barrier function, and bilirubin clearance. Maternal milk contains bioactive oligosaccharides such as 3'-sialyllactose (3'SL), while the sialyltransferase St3gal4 regulates endogenous glycosylation. Their contributions to intestinal development and neonatal hyperbilirubinemia, however, remain poorly understood.</p><p><strong>Methods: </strong>We employed the humanized UGT1 (hUGT1) mouse model, which spontaneously develops neonatal hyperbilirubinemia due to delayed induction of liver and intestinal UGT1A1. By combining this jaundiced background with maternal milk lacking 3'SL, we examined the roles of maternal milk 3'SL and the pup St3gal4 gene in neonatal intestinal development, bilirubin metabolism, and long-term gut function.</p><p><strong>Results: </strong>Neonates deprived of maternal milk 3'SL exhibited reduced survival, growth retardation, shortened intestinal length, and aggravated hyperbilirubinemia, associated with markedly decreased intestinal UGT1A1 expression. Transcriptomic analyses revealed downregulation of intestinal maturation markers and secretory lineage genes, accompanied by upregulation of fetal and pancreatic gene programs. RT-qPCR, immunohistochemistry, and Western blot confirmed reduced expression of goblet cell (Muc2), Paneth cell (Lyz1, Defa5), and UGT1A1 proteins in 3'SL-deficient pups. Mechanistically, St3gal4 deficiency was associated with aberrant activation of pancreatic gene programs, while 3'SL deficiency correlated with reduced HNF4α signaling, together implicating disrupted intestinal epithelial identity. Remarkably, these developmental defects were associated with long-term consequences: St3gal4-deficient mice exhibited heightened susceptibility to DSS-induced colonic injury in adulthood, with greater weight loss and reduced survival.</p><p><strong>Conclusions: </strong>Collectively, these findings indicate that maternal milk-derived 3'SL and the St3gal4 gene are essential for establishing neonatal intestinal identity, promoting secretory lineage differentiation, and sustaining intestinal UGT1A1 expression. These findings reveal complementary roles of maternal milk-derived 3'SL and St3gal4-dependent sialylation in safeguarding neonatal survival and shaping long-term intestinal resilience.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101924"},"PeriodicalIF":8.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intestinal GPR128 deficiency protects against acetaminophen-induced liver injury through the gut-liver axis.","authors":"Chengbo Wang, Jingyu Cao, Minglei Yang, Jing Qiao, Deng Pan, Lihua He, Dazhong Wang, Rui Jia, Yaodong Zhang, Lidan Cui, Zhenlong Li, Zhibin Zhao, Shenhai Gong, Faisal Aziz, Fang Zhou, Ya Li, Xiangzhan Zhu","doi":"10.1016/j.jcmgh.2026.101925","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101925","url":null,"abstract":"<p><strong>Background & aims: </strong>Acetaminophen (APAP)-induced liver injury (AILI) is the leading cause of acute liver failure, but the intestinal host gene-microbe interactions that regulate AILI through the gut-liver axis remain poorly defined. We investigated whether intestinal GPR128 regulates susceptibility to AILI and sought to elucidate the underlying microbiota-dependent molecular mechanisms.</p><p><strong>Methods: </strong>We used intestinal GPR128-deficient mice challenged with APAP to assess liver injury, goblet cell and mucus-layer integrity, gut microbiota composition, and microbial β-galactosidase activity. The roles of Akkermansia muciniphila, dietary gentisic acid (GA), and the HSP90α-CBFβ/RUNX1-UPP1 pathway were evaluated using mouse, cellular, biochemical, and metabolic assays.</p><p><strong>Results: </strong>Intestinal GPR128 deficiency protected mice from AILI and was associated with preservation of goblet cell mucus-layer homeostasis and enrichment of mucus-associated A. muciniphila. A. muciniphila-associated β-galactosidase activity promoted dietary GA liberation and increased systemic GA levels. GA appeared to act through HSP90α and concomitantly reduced its interaction with CBFβ, thereby inhibiting CBFβ nuclear translocation and suppressing RUNX1-dependent UPP1 transcription. Inhibition of UPP1 reduced uridine-derived lactate production and ameliorated AILI.</p><p><strong>Conclusions: </strong>Intestinal GPR128 deficiency protects against AILI through a gut-liver axis involving goblet cell-associated A. muciniphila, microbial β-galactosidase, dietary GA, and the HSP90α-CBFβ/RUNX1-UPP1 pathway. These findings identify this cascade as a potential therapeutic target for APAP-induced liver injury.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101925"},"PeriodicalIF":8.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jean Agnetti, Samy Cherief, Christophe Desterke, Vanessa Bou-Malham, Nassima Benzoubir, Tuan Zea Tan, Jean Paul Thiery, Didier Samuel, Ama Gassama-Diagne
{"title":"Persistent Hepatocyte Plasticity and Lipid Metabolic Reprogramming After Hepatitis C Virus Cure.","authors":"Jean Agnetti, Samy Cherief, Christophe Desterke, Vanessa Bou-Malham, Nassima Benzoubir, Tuan Zea Tan, Jean Paul Thiery, Didier Samuel, Ama Gassama-Diagne","doi":"10.1016/j.jcmgh.2026.101927","DOIUrl":"https://doi.org/10.1016/j.jcmgh.2026.101927","url":null,"abstract":"<p><strong>Background and aims: </strong>Chronic hepatitis C virus (HCV) infection disrupts hepatocyte polarity and promotes epithelial-mesenchymal transition (EMT), contributing to liver disease progression. Although direct-acting antivirals (DAAs) eradicate HCV infection in most patients, the risk of fibrosis progression and hepatocellular carcinoma persists after viral clearance. Whether antiviral cure fully restores hepatocyte differentiation, polarity, and epithelial identity programs remains unclear. We investigated whether HCV-induced EMT and lipid metabolism alterations are fully reversible following DAA treatment.</p><p><strong>Methods: </strong>Huh7 hepatoma cells and Huh7 cells stably expressing a full-length HCV replicon were cultured in three-dimensional Matrigel to assess morphogenesis, polarity-associated features, and EMT. Spheroid morphology, canalicular-like organization, EMT markers, and transcriptomic signatures were analyzed using microscopy, immunofluorescence, RT-qPCR, and microarray analysis. The effects of DAA treatment (sofosbuvir with or without velpatasvir) were evaluated in vitro. Publicly available transcriptomic data from liver biopsies collected before therapy and within five days after its completion, were analyzed.</p><p><strong>Results: </strong>HCV replicon expression altered canalicular-like organization and induced actin-rich protrusions in 90% of Huh7-R spheroids. DAA treatment efficiently suppressed HCV replicon expression and partially restored epithelial morphology, reducing protrusions to 25%, without normalizing them to the control level (2.5%). EMT-associated changes, including reduced E-cadherin and increased N-cadherin expression, were only partially corrected by DAA treatment. Transcriptomic EMT scoring showed persistent mesenchymal features in DAA-treated cells and in patient biopsies collected at the end of treatment. In parallel, genes involved in lipid metabolism and hepatocyte differentiation remained dysregulated.</p><p><strong>Conclusions: </strong>These findings show incomplete restoration of epithelial organization after suppression of HCV replicon expression in vitro and incomplete normalization of selected transcriptional signatures at the end of DAA treatment in patient liver samples. They suggest that cellular plasticity and metabolic reprogramming may persist after treatment and contribute to long-term liver disease risk.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101927"},"PeriodicalIF":8.2,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zepei Li, Ye Qiu, Tom Luedde, Hans H Bock, Carsten Münk
{"title":"Host Restriction Factors in Hepatitis B Virus-Related Liver Disease and Hepatocellular Carcinoma: Mechanisms of Viral-Host Interplay and Implications for Therapy.","authors":"Zepei Li, Ye Qiu, Tom Luedde, Hans H Bock, Carsten Münk","doi":"10.1016/j.jcmgh.2026.101920","DOIUrl":"10.1016/j.jcmgh.2026.101920","url":null,"abstract":"<p><p>Chronic hepatitis B virus infection is a leading cause of liver cirrhosis and hepatocellular carcinoma, imposing a substantial global health burden. The natural history of persistent hepatitis B virus infection progresses from chronic inflammation to fibrosis, cirrhosis, and malignant transformation, driven in part by the stability of covalently closed circular DNA within hepatocyte nuclei. Nucleos(t)ide analogues effectively suppress viral replication but rarely lead to a functional cure, necessitating long-term therapy and carrying a residual risk of resistance. Peginterferon-α can induce a functional cure in a minority of patients but its clinical use is limited by frequent adverse effects. Host restriction factors-cellular proteins that directly inhibit viral replication-act at multiple stages of the hepatitis B virus infection cycle, including entry, covalently closed circular DNA transcription, RNA stability, and virion release. Hepatitis B virus counters these intrinsic defenses through viral proteins such as HBx, establishing a dynamic interplay between viral and host factors that shapes infection outcome and disease progression. This review consolidates recent advances in understanding the roles of host restriction factors in hepatitis B virus pathogenesis and their mechanistic links to cirrhosis and hepatocellular carcinoma. We also highlight emerging therapeutic strategies aimed at targeting these host-virus interactions to disable hepatitis B virus persistence and thereby reduce hepatitis B virus-related disease burden.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101920"},"PeriodicalIF":8.2,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149197803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"C-X-C Chemokine Receptor Type 4-Enriched B Cells Foster Immunosuppression and Gastric Cancer Progression in Male Mice via the Adenosine-Interleukin10 Axis.","authors":"Yu-Xian Li, Yuan Qiu, Hang Zhong, Meng-Qiu Huang, Yuan-Yuan Zhang, Wen-Jia Li, Yang Shen, Ying Wang, Bao-Hang Zhu, Yuan Zhuang, Ping Cheng, Ting Yu, Rong Wang, Ling Liu, Masami Yamamoto, Tetsuya Tsukamoto, Sachiyo Nomura, Weisan Chen, Zhen-Quan Duan, Quan-Ming Zou, Dai-Yuan Ma, Liu-Sheng Peng","doi":"10.1016/j.jcmgh.2026.101917","DOIUrl":"10.1016/j.jcmgh.2026.101917","url":null,"abstract":"<p><strong>Background & aims: </strong>B cells are one major component of immune cells infiltrated in human solid tumors. However, the role of tumor-infiltrating B cells in mediating disease progression of human gastric cancer remains elusive.</p><p><strong>Methods: </strong>Flow cytometry, immunohistochemistry, and immunofluorescence were performed to analyze the prevalence and phenotypic and functional features of B cells in different samples of patients with gastric cancer. B cells and T cells were purified and cultured ex vivo for regulation and functional assays. Tumor responses to B-cell deficiency or adoptively transferred IL10 knockout B cells or blockade of C-X-C chemokine receptor type 4 or CD73 were measured in an in vivo syngeneic male mouse model.</p><p><strong>Results: </strong>Patients with gastric cancer showed a significantly increased B-cell enrichment in the tumor tissues during disease progression. The accumulation of B cells in the tumor tissues was mediated by the C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 chemotactic axis. Although a similar phenotypic feature of B cells was shown between tumor and nontumor tissues, tumor-infiltrating B cells effectively suppressed T-cell immunity and accelerated tumor growth via interleukin10 ex vivo and in vivo. In addition, tumor-associated adenosine could promote the production of interleukin10 by B cells, and inhibiting the rate limiting enzyme CD73 for adenosine production in vivo significantly suppressed interleukin10 production of tumor-infiltrating B cells and attenuated gastric cancer growth.</p><p><strong>Conclusions: </strong>Our study uncovers a novel mechanism that C-X-C chemokine receptor type 4-enriched B cells in gastric tumor tissues suppress T cell immunity via adenosine-mediated interleukin10 production, which may contribute to tumor immune escape and disease progression of gastric cancer.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101917"},"PeriodicalIF":8.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149149575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Microbiota-Driven C-C Motif Chemokine Ligand 25-C-C Motif Chemokine Receptor 9 Axis Reprograms Intestinal Type 2 Innate Lymphoid Cells in the Distal Small Intestine to Promote Metabolic Dysfunction in Obesity.","authors":"Ryosuke Kasuga, Toshiaki Teratani, Kentaro Miyamoto, Takahiro Suzuki, Takeru Amiya, Shuhei Tanemura, Yukie Nakadai, Haruka Okada, Makoto Ueno, Takaya Tabuchi, Nobuhito Taniki, Keisuke Ojiro, Yohei Mikami, Yuzo Koda, Susumu Inamine, Sachiyo Yoshio, Takumi Kawaguchi, Takanori Kanai, Nobuhiro Nakamoto","doi":"10.1016/j.jcmgh.2026.101919","DOIUrl":"10.1016/j.jcmgh.2026.101919","url":null,"abstract":"<p><strong>Background & aims: </strong>Metabolically unhealthy obesity is characterized by chronic inflammation and metabolic dysfunction; however, how intestinal immune organization shapes systemic metabolic outcomes remains unclear. We investigated whether region-specific intestinal immune remodeling contributes to obesity-associated metabolic dysfunction.</p><p><strong>Methods: </strong>Human serum chemokine profiling was performed in patients with severe obesity before and after bariatric surgery. Diet-induced obesity models in male mice, microbiota manipulation, single-cell RNA sequencing, genetic and pharmacologic C-C motif chemokine receptor 9 perturbation, parabiosis, and adoptive transfer experiments were used to define the mechanisms regulating intestinal innate lymphoid cells.</p><p><strong>Results: </strong>The levels of circulating C-C motif chemokine ligand 25 correlated with visceral adiposity in patients with severe obesity and declined following bariatric surgery. Segment-specific analyses demonstrated preferential upregulation of C-C motif chemokine ligand 25 and C-C motif chemokine receptor 9 in the distal small intestine under metabolic stress. In obese mice, microbiota-dependent induction of epithelial C-C motif chemokine ligand 25 promoted C-C motif chemokine receptor 9-dependent accumulation of type 2 innate lymphoid cells in the ileum, accompanied by reduced adipose-resident type 2 innate lymphoid cells. Small-intestinal type 2 innate lymphoid cells underwent selective inflammatory reprogramming toward a type 1 innate lymphoid cells-like phenotype, whereas adipose tissue type 2 innate lymphoid cells remained comparatively stable. Genetic or pharmacologic disruption of C-C motif chemokine receptor 9 signaling reversed obesity-associated skewing of type 2 innate lymphoid cell distribution, suppressed intestinal inflammatory remodeling, preserved epithelial barrier integrity, and improved glucose homeostasis without affecting body weight, even in the absence of adaptive immunity. Parabiosis and adoptive transfer experiments further demonstrated that disruption of the C-C motif chemokine ligand 25-C-C motif chemokine receptor 9 axis redirected circulating type 2 innate lymphoid cells from the small intestine toward peripheral tissues.</p><p><strong>Conclusions: </strong>These findings identify the distal small intestine as a microbiota-responsive immune trafficking checkpoint linking regional immune remodeling to systemic metabolic dysfunction and establish intestinal immune positioning pathways as potential therapeutic targets in metabolically unhealthy obesity.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101919"},"PeriodicalIF":8.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149148831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}